QUOIN PHARMACEUTICALS LT-ADR
QNRXNASDAQ🏆 #4889 by market capEarnings Nov 4US Equity
$4.06▲ $0.03 (+0.62%)
Market closed · at closeTrack QNRX
Get earnings, price moves & breaking news on Telegram
24h▲ 0.6%
7d▲ 1.8%
14d▲ 1.0%
30d▼ 28.5%
ytd▼ 71.1%
1y▼ 67.3%
🏦Market Cap
$683M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $4.06 – $4.06
- 52-Week Range
- $3.25 – $23.50
- Volume (shares)
- 419
- Avg Volume (shares)
- —
- Shares Outstanding
- 168.2M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-12.11
- Dividend Yield
- —
- Dilution (1yr)
- +28021.7%
QUOIN PHARMACEUTICALS LT-ADR
QNRXFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$16M▲ +71.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$14M▲ +72.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.5M▲ +28021.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3.8B▲ +$3.8B YoY
StockOtter · stockotter.spaceAbout QUOIN PHARMACEUTICALS LT-ADR
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
11 analysts
Strong Buy2
Buy8
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.